Myriad Genetics' GAAP loss for 2021 was $27.2 million, down 8.3 times from $223.7 million in the previous year. Revenue increased 24% to $690.6 million from $557.1 million a year earlier.
Myriad Genetics' GAAP loss for 2021 was $27.2 million, down 8.3 times from $223.7 million in the previous year. Revenue increased 24% to $690.6 million from $557.1 million a year earlier. 
myriad.com
English (US) 